174 applications were received for 23 eligible products under Target Segment IV - Other Chemical Synthesis Based KSMs/ Drug Intermediates/APIs.
The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
Be One is a 100% Ayurvedic health and wellness supplement.
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
Subscribe To Our Newsletter & Stay Updated
